Skip to main content
. 2014 May 15;9(5):e94883. doi: 10.1371/journal.pone.0094883

Figure 2. Tumor growth after tumor challenge in C57BL/6 mice immunized with recMAGE-A3 formulated with different immunostimulants.

Figure 2

The mice (n = 5) were immunized with recMAGE-A3 (10 µg of antigen) formulated with different immunostimulants and challenged with TC1-MAGE-A3 cells. On day 84, standard errors of the mean are shown and the number of mice remaining tumor-free is indicated for each group. On Day 84, the recMAGE-A3+AS15 group was found different from any other group (p<0.01). Also, tumor growth rate was decreased in the recMAGE-A3+AS15 group, compared with the other groups (p<0.01).